Author:
Baechler Sébastien,Hobbs Robert F.,Boubaker Ariane,Buchegger Franz,He Bin,Frey Eric C.,Sgouros George
Funder
National Institutes of Health
National Cancer Institute
Reference48 articles.
1. Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs;Kwekkeboom;J. Nucl. Med.,2005
2. Phase I study of peptide receptor radionuclide therapy with [In-DTPA]octreotide: The Rotterdam experience;Valkema;Semin. Nucl. Med.,2002
3. Candidates for peptide receptor radiotherapy today and in the future;Reubi;J. Nucl. Med.,2005
4. Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors;Kwekkeboom;Endocr. Relat. Cancer,2010
5. Comparison of [(177)Lu-DOTA(0),Tyr(3)]octreotate and [(177)Lu-DOTA(0),Tyr(3)]octreotide: Which peptide is preferable for PRRT?;Esser;Eur. J. Nucl. Med. Mol. Imaging,2006
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献